IRF8 and melanoma: To further investigate the correlation between anti-PD-1 immune checkpoint blockade therapy and functional features of IRF1, JAK2, CD8A, IRF8, STAT5B, and SELL in melanoma, differential signature enrichment analysis was performed via GSVA based on the GSE78220 datasets (n = 28).